Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding hepatitis C in the previous week. Topics include all stories related to hepatitis C as well as personal stories and events.
Week Ending 11/16/2014
‘Revolutionary new drugs are curing hepatitis C, halting a disease that can corrode the liver to the point of cirrhosis, cancer and death. But state restrictions on who can get the costly drugs are keeping them out of reach for some of the poorest patients.’
‘The American Journal of Medicine (AJM) announces the availability of an original, comprehensive, online Hepatitis C Resource Center dedicated to providing primary care providers and specialists with the latest information on the screening, diagnosis, treatment and management of Hepatitis C (HCV). Elsevier, a world-leading provider of scientific, technical and medical information products and services, publishes AJM.’
‘Hepatitis C (HCV) patients with cirrhosis are tough to treat. And those who have previously failed therapy are especially difficult. But 24 weeks of treatment with a newly approved drug combination, sofosbuvir and ledipasvir (Harvoni), cured 97% of patients in a double-blinded, controlled trial, according to Marc Bourliere, MD, of the Saint Joseph Hospital in Marseilles, France.’
‘The American Academy of HIV Medicine (AAHIVM) announces the creation of the new AAHIVM Institute for Hepatitis C. The AAHIVM board of directors recently voted unanimously to create the Institute to spearhead current and future AAHIVM programs and activities focused on HCV. The Institute’s goal is to advance hepatitis C (HCV) care through education, professional development and advocacy. Vice chair of the AAHIVM board of directors, Dr. Margaret Hoffman-Terry, will serve as the director of the institute.’
‘Patients with chronic hepatitis C virus infection and advanced fibrosis or cirrhosis who attained sustained virological response (SVR) had survival comparable with that of the general population, whereas patients who did not attain SVR had reduced survival, according to a study in the November 12 issue of JAMA.’
‘A new study has found no association between hepatitis C and diabetes in the United States, despite previous research that suggested a clear link. Maryland-based researchers looked at 15,128 participants in the National Health and Nutrition Examination Survey between 1999 and 2000.’